| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/12/2006 | CN1263478C Shuangdan extracts and its injection for treating coronary disease and angina pectoris and preparation thereof |
| 07/12/2006 | CN1263474C A topical anti-itch formulation and process for preparation thereof |
| 07/12/2006 | CN1263473C Chiese patent drug for treating apoplexia and its preparation method |
| 07/12/2006 | CN1263472C Gingko drop pill for prevention and treatment of cardiovascular and cerebrovascular disease |
| 07/12/2006 | CN1263459C Cell growth regulating factor O and its preparation process |
| 07/12/2006 | CN1263448C Compound formulation for treating hypertension |
| 07/12/2006 | CN1263447C Stable solution of reduced coenzyme Q |
| 07/12/2006 | CN1263389C Tea of whiteflower red root and producing method |
| 07/12/2006 | CA2489780A1 Methods for preventing or treating a condition or a disease associated with angiogenesis |
| 07/11/2006 | US7074930 Amine salts of an integrin receptor antagonist |
| 07/11/2006 | US7074929 Certain alkylene diamine-substituted heterocycles |
| 07/11/2006 | US7074925 N-substituted derivatives of 5-oxyiminobarbituric acid |
| 07/11/2006 | US7074833 Use of the (1S,2R) enantiomer of milnacipran for the preparation of a drug |
| 07/11/2006 | US7074815 4-[3,5-bis-(2-hydroxy-phenyl)-[1,2,4]triazol-1-yl]-benzoic acid derivatives for treating an excess of metal in the body |
| 07/11/2006 | US7074814 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antiarthritic agents ; psoriasis |
| 07/11/2006 | US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 07/11/2006 | US7074802 analgesics; antipyretics; antiinflammatory agents; antiarthritic agents |
| 07/11/2006 | US7074800 Quinazoline derivatives as angiogenesis inhibitors |
| 07/11/2006 | US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 07/11/2006 | US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides |
| 07/11/2006 | US7074792 antiserotonine agents; central nervous system disorders; Alzheimer's disease |
| 07/11/2006 | US7074789 Kinase inhibitors |
| 07/11/2006 | US7074782 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor |
| 07/11/2006 | US7074780 Substituted phenylcyclohexanecarboxamides and their use |
| 07/11/2006 | US7074774 Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for treating cardio-cerebrovascular anoxemia |
| 07/11/2006 | US7074766 antiinflammatory agents; autoimmune diseases; thrombosis; viricides; blood disorders; antitumor agents |
| 07/11/2006 | US7074408 Use of integrin antagonists to inhibit angiogenesis |
| 07/11/2006 | US7074407 immunizing with fragments of CETP (cholesteryl ester transfer protein) which may be conjugated to a carrier, such as KLH (keyhole limpet hemocyanin) or ovalbumin, to increase immunogenicity |
| 07/11/2006 | US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 07/11/2006 | US7074402 Treating different types of neuronal dysfunction, including stroke, Alzheimer's disease, Parkinson's disease, Huntington disease, neuroimmunological disorders such as multiple scelrosis |
| 07/11/2006 | US7074401 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 07/11/2006 | CA2395114C 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 07/11/2006 | CA2376876C New isoindoloindolone derivatives, the process for preparing them and the pharmaceutical compounds that contain them |
| 07/11/2006 | CA2367306C New cycloheptene compounds, their preparation process and the pharmaceutical compounds containing them |
| 07/11/2006 | CA2341375C Extended release buccal bioadhesive tablet |
| 07/11/2006 | CA2319201C Celecoxib compositions |
| 07/11/2006 | CA2262566C Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect |
| 07/11/2006 | CA2215233C Terminal carboxy or tetrazole groups containing dialkyl ethers |
| 07/11/2006 | CA2090584C Steroids having a methylene lactone group at position 17, process for preparing the same and their intermediates, use of the same as drugs and pharmaceutical compositions comprising the same |
| 07/06/2006 | WO2006071035A1 Novel ([1,3]thiazolo[5,4-b]pyridin-2-yl)-2-carboxamide derivatives |
| 07/06/2006 | WO2006070943A1 Condensed imidazole compound and use thereof |
| 07/06/2006 | WO2006070927A1 Pyrimidinylisoxazol derivative |
| 07/06/2006 | WO2006070878A1 Carboxylic acid derivative or salt thereof |
| 07/06/2006 | WO2006070874A1 Hypoxic response promoter |
| 07/06/2006 | WO2006070873A1 Adiponectin inducer or secretagogue |
| 07/06/2006 | WO2006070856A1 Sesamin/episesamin compositions |
| 07/06/2006 | WO2006070276A1 Process for preparing perindopril erbumine |
| 07/06/2006 | WO2006070248A1 Methods for the preparation of stable pharmaceutical solid dosage forms of atorvastatin and amlodipine |
| 07/06/2006 | WO2006070022A2 Medicaments containing selenium for the treatment of endothelial vascular diseases |
| 07/06/2006 | WO2006069788A1 Organic compounds |
| 07/06/2006 | WO2006069705A1 Directly pressed indapamide tablets with delayed release of the active substance |
| 07/06/2006 | WO2006069512A1 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal composition containing them |
| 07/06/2006 | WO2006044856A3 Use of a2a adenosine receptor agonists |
| 07/06/2006 | WO2006035286A3 Process for preparating enantiomerically pure fluvastatin sodium and a novel polymorphic form thereof |
| 07/06/2006 | WO2006011859A3 Preparation of hydrochloride salts of tetrazole derivative |
| 07/06/2006 | WO2005077400A8 Cysteine rich peptides for improving thiol homeostasis |
| 07/06/2006 | US20060149072 Selective to alpha2B or alpha2C adrenergic receptors, minimal cardivascular or sedatory activity; treating visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |
| 07/06/2006 | US20060149039 Pseudo-native chemical ligation |
| 07/06/2006 | US20060149033 IGF antagonist peptides |
| 07/06/2006 | US20060148901 Acylated 4-amidino-and-4-guanidinobenzylamines for inhibition of plasma kallikrein |
| 07/06/2006 | US20060148900 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 07/06/2006 | US20060148878 Pseudopolymorphic forms of carvedilol |
| 07/06/2006 | US20060148862 Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 07/06/2006 | US20060148844 Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation |
| 07/06/2006 | US20060148834 Novel coumarin-amide derivatives and its preparation, said drug composition and its use |
| 07/06/2006 | US20060148831 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 07/06/2006 | US20060148821 N,N-disubstituted diazocycloalkanes |
| 07/06/2006 | US20060148819 Chemical compounds |
| 07/06/2006 | US20060148814 4-(2-Pyridyl)-1-amino(thio)carbonylpiperazine derivatives are antagonists of the mGluR5 receptor |
| 07/06/2006 | US20060148806 Quinolone derivative or salt thereof |
| 07/06/2006 | US20060148802 Use of compounds that stimulate cgmp |
| 07/06/2006 | US20060148798 Antiinflammatory agents; cardiovascular disorders; antidiabetic agents;central nervous system diosrders ; anticancer agents |
| 07/06/2006 | US20060148794 Neuropeptide Y antagonist; antiarthritic agents; cardiovascular disorders; antidiabetic agents; kidney disorders; eating disorders; obesity |
| 07/06/2006 | US20060148791 Glutamate receptor antagonists |
| 07/06/2006 | US20060148768 Vitamin d3 lactone derivatives |
| 07/06/2006 | US20060148760 Method for the sysnthesis of compounds of formula I and their uses thereof |
| 07/06/2006 | US20060148751 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 07/06/2006 | US20060148733 Composition containing total triterpenoid saponins extracted from bamboo, and the preparation method and use thereof |
| 07/06/2006 | US20060148713 Use of exendins and agonists thereof for the reduction of food intake |
| 07/06/2006 | US20060148707 Use of ligands to GABA beta receptors |
| 07/06/2006 | US20060148691 Sustained release preparation for therapy of coronary stenosis or obstruction |
| 07/06/2006 | US20060148683 Detection and treatment of intravascular lesions |
| 07/06/2006 | US20060148675 Methods of reducing angiogenesis |
| 07/06/2006 | US20060148083 Culturing whole bone marrow from mammal in medium comprising fibroblast growth factor-2 and epidermal growth factor to produce neural progenitor cell carrying gene that effects local production of biological compound, administering to tumor diseased tissue; gene therapy |
| 07/06/2006 | US20060148082 Method for delivering a biological compound using neural progenitor cells derived from whole bone marrow |
| 07/06/2006 | US20060148055 Oxidised fragments of apolioprotein B and their uses |
| 07/06/2006 | US20060148030 Nuclear receptor err y 3 |
| 07/06/2006 | US20060148018 Insulin-like growth factor binding protein-4 protease |
| 07/06/2006 | US20060147973 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 07/06/2006 | US20060147920 Method of judging inflammatory disease |
| 07/06/2006 | US20060147568 Blood pressure-lowering agent, vascular flexibility -improving agent and foods having these functions imparted thereto |
| 07/06/2006 | US20060147548 Therapeutic delivery of carbon monoxide |
| 07/06/2006 | US20060147521 Sustained release ranolazine formulations |
| 07/06/2006 | US20060147437 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/06/2006 | US20060146644 System for producing micro-cluster liquids |
| 07/06/2006 | DE112004001572T5 Verfahren Method |
| 07/06/2006 | DE102004062257A1 Direkt verpresste Indapamid-Tabletten mit verzögerter Wirkstofffreisetzung Directly compressed indapamide sustained release tablets |
| 07/06/2006 | CA2594325A1 Condensed imidazole compound and use thereof |
| 07/06/2006 | CA2592532A1 Sesamin/episesamin compositions with improved bioavailability |
| 07/06/2006 | CA2592435A1 Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells |